Nektar Therapeutics (ITH.F) Q4 2023 Earnings

Mar 4Confirmed
Q1 2023
Q2 2023
Q3 2023
Q4 2023
-0.2
-0.2
-0.2
-0.19

Details

Expected EPS
-0.19387179691999998
Actual EPS
-0.2026772
Surprise EPS
-0.01
Surprise Percent
-4.54%

Description

⁨Nektar Therapeutics⁩ (⁦ITH.F⁩) has reported earnings of ⁦-0.2026772⁩ per share for ⁦Q4 2023⁩.

0 Comments

Share your thoughts